Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape

od Oosting, Sjoukje F, Fehrmann, Rudolf S, de Vries, Elisabeth G E
Wydane w ESMO Open (2017)

Regulators of homologous recombination repair as novel targets for cancer treatment

od Krajewska, Małgorzata, Fehrmann, Rudolf S. N., de Vries, Elisabeth G. E., van Vugt, Marcel A. T. M.
Wydane w Front Genet (2015)

ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1

od Renes, Johan, de Vries, Elisabeth G E, Nienhuis, Edith F, Jansen, Peter L M, Müller, Michael
Wydane 1999

The analysis of longitudinal quality of life measures with informative drop-out: a pattern mixture approach

od Post, Wendy J., Buijs, Ciska, Stolk, Ronald P., de Vries, Elisabeth G. E., le Cessie, Saskia
Wydane 2009

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid

od Nienhuis, Hilde H., Arjaans, Marlous, Timmer-Bosscha, Hetty, de Vries, Elisabeth G.E., Schröder, Carolina P.
Wydane w Oncotarget (2015)

Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage

od Altena, Renske, Fehrmann, Rudolf S. N., Boer, Hink, de Vries, Elisabeth G. E., Meijer, Coby, Gietema, Jourik A.
Wydane w PLoS One (2015)

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology

od Giuliani, Rosa, Tabernero, Josep, Cardoso, Fatima, McGregor, Keith Hanson, Vyas, Malvika, de Vries, Elisabeth G E
Wydane w ESMO Open (2019)

Automated mass spectrometric analysis of urinary and plasma serotonin

od de Jong, Wilhelmina H. A., Wilkens, Marianne H. L. I., de Vries, Elisabeth G. E., Kema, Ido P.
Wydane 2010

Inhibition of IGF-1R-Dependent PI3K Activation Sensitizes Colon Cancer Cells Specifically to DR5-Mediated Apoptosis But Not to rhTRAIL

od Pennarun, Bodvael, Kleibeuker, Jan H., Oenema, Tjitske, Stegehuis, Janet H., de Vries, Elisabeth G.E., de Jong, Steven
Wydane w Anal Cell Pathol (Amst) (2010)

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

od Arjaans, Marlous, Schröder, Carolina P., Oosting, Sjoukje F., Dafni, Urania, Kleibeuker, Josée E., de Vries, Elisabeth G.E.
Wydane w Oncotarget (2016)

Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells

od van der Deen, Margaretha, Homan, Sandra, Timmer-Bosscha, Hetty, Scheper, Rik J, Timens, Wim, Postma, Dirkje S, de Vries, Elisabeth G
Wydane 2008

Functional Genomic mRNA Profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types

od Lamberts, Laetitia E., de Groot, Derk Jan A., Bense, Rico D., de Vries, Elisabeth G.E., Fehrmann, Rudolf S.N.
Wydane w Oncotarget (2015)

Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort

od Taghizadeh, Niloofar, Vonk, Judith M., Hospers, Jeannette J., Postma, Dirkje S., de Vries, Elisabeth G. E., Schouten, Jan P., Boezen, H. Marike
Wydane w Cancer Causes Control (2014)

Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine

od Pool, Martin, de Boer, H. Rudolf, Hooge, Marjolijn N. Lub-de, van Vugt, Marcel A.T.M., de Vries, Elisabeth G.E.
Wydane w Theranostics (2017)

(89)Zr-Onartuzumab PET imaging of c-MET receptor dynamics

od Pool, Martin, Terwisscha van Scheltinga, Anton G. T., Kol, Arjan, Giesen, Danique, de Vries, Elisabeth G. E., Lub-de Hooge, Marjolijn N.
Wydane w Eur J Nucl Med Mol Imaging (2017)

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies

od Paluch-Shimon, Shani, Cherny, Nathan I, de Vries, Elisabeth G E, Dafni, Urania, Piccart, Martine J, Latino, Nicola Jane, Cardoso, Fatima
Wydane w ESMO Open (2020)

Translating Pharmacogenomics: Challenges on the Road to the Clinic

od Swen, Jesse J, Huizinga, Tom W, Gelderblom, Hans, de Vries, Elisabeth G. E, Assendelft, Willem J. J, Kirchheiner, Julia, Guchelaar, Henk-Jan
Wydane 2007

Fas Ligand Expression in Lynch Syndrome-Associated Colorectal Tumours

od Koornstra, Jan J., de Jong, Steven, Boersma-van Eck, Wietske, Zwart, Nynke, Hollema, Harry, de Vries, Elisabeth G.E., Kleibeuker, Jan H.
Wydane 2008

(89)Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment

od Pool, Martin, Kol, Arjan, de Jong, Steven, de Vries, Elisabeth G. E., Lub-de Hooge, Marjolijn N., Terwisscha van Scheltinga, Anton G.T.
Wydane w MAbs (2017)

Transcriptional effects of copy number alterations in a large set of human cancers

od Bhattacharya, Arkajyoti, Bense, Rico D., Urzúa-Traslaviña, Carlos G., de Vries, Elisabeth G. E., van Vugt, Marcel A. T. M., Fehrmann, Rudolf S. N.
Wydane w Nat Commun (2020)